
doi: 10.1042/cs20170137
pmid: 28533270
Inhibitors of phosphodiesterase 5 (PDE5) – sildenafil citrate (Viagra; Pfizer) and vardenafil hydrochloride (Levitra; Bayer/GlaxoSmithKline) – approved for the treatment of erectile dysfunction and pulmonary arterial hypertension also rescue the loss of cystic fibrosis (CF) chloride channel function and the mislocalization of F508del-CFTR in affected tissues in CF. Can PDE5 inhibitors provide a therapeutic strategy which combines ability to correct the basic ion transport defect and to control de-regulated lung inflammation in CF?
Immunology & Inflammation, Molecular Interactions, Macrophages, Imidazoles, Cystic Fibrosis Transmembrane Conductance Regulator, Molecular Bases of Health & Disease, Piperazines, Vardenafil Dihydrochloride, Humans, Sulfones
Immunology & Inflammation, Molecular Interactions, Macrophages, Imidazoles, Cystic Fibrosis Transmembrane Conductance Regulator, Molecular Bases of Health & Disease, Piperazines, Vardenafil Dihydrochloride, Humans, Sulfones
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
